注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
LAVA Therapeutics NV(原名:Lava Therapeutics BV)是一家总部位于荷兰的生物技术研发服务提供商。该公司专注于开发下一代的Vdelta T细胞,该细胞含有双特异性抗体以对抗癌症。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Kapil Dhingra | 65 | 2021 | Non-Executive Chairman |
Karen J. Wilson | 61 | 2021 | Independent Non-Executive Director |
Stephen Allen Hurly | 56 | 2019 | CEO, President & Executive Director |
James Julian Noble | 65 | 2022 | Independent Non-Executive Director |
Andrea van Elsas | 58 | 2018 | Chairman of Advisory Board |
Padmanee Sharma | - | 2020 | Member of Advisory Board |
James Patrick Allison | - | 2020 | Member of Advisory Board |
K. Dane Wittrup | - | - | Member of Advisory Board |
Madhav V. Dhodapkar | - | - | Member of Advisory Board |
Jay Thomas Backstrom | 69 | 2022 | Non-Executive Director |
Dieter Kabelitz | - | - | Member of Advisory Board |
Mary E. Wadlinger | 64 | 2023 | Non-Executive Director |
Christy J. Oliger | 54 | 2023 | Non-Executive Director |
Peter A. Kiener | 72 | 2023 | Non-Executive Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核